Jw Asset Management, LLC Pharming Group N.V. Transaction History

Jw Asset Management, LLC

  • $222 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$9.26 - $11.6 $1.57 Million - $1.96 Million
-169,225 Closed
0 $0
Q2 2021

Aug 06, 2021
SELL
$10.95 - $13.58 $223,029 - $276,597
-20,368 Reduced 10.74%
169,225 $1.91 Million
Q1 2021

May 14, 2021
SELL
$12.44 - $14.99 $21.2 Million - $25.6 Million
-1,706,348 Reduced 90.0%
189,593 $2.43 Million
Q4 2020

Feb 05, 2021
BUY
$14.5 - $16.7 $27.5 Million - $31.7 Million
1,895,941 New
1,895,941 $2.95 Million

Others Institutions Holding PHAR

# of Institutions
5
Shares Held
66.9K
Call Options Held
0
Put Options Held
0
View Full List

About Pharming Group N.V.

PHAR Quotes by TradingView
  • Ticker PHAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,241,400
  • Market Cap $491M
  • Description
  • Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...
More about PHAR
Track This Portfolio

Track Jw Asset Management, LLC Portfolio

Follow Jw Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jw Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jw Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email